These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 8555647)

  • 1. Thymosin fraction 5 does not influence urinary tract carcinogenesis by phenacetin and N-butyl-N-(4-hydroxybutyl)nitrosamine in NON/Shi mice.
    Murai T; Iwata H; Mori S; Hato F; Kimura S; Kinoshita Y; Wada S; Kishimoto T; Makino S; Oohara T
    Oncol Res; 1995; 7(3-4):139-44. PubMed ID: 8555647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A study of antitumor effects of thymosin on rat and mouse urinary bladder carcinoma induced by N-butyl-N-(4-hydroxybutyl)-nitrosamine.
    Wada S; Kinoshita Y; Kamizuru M; Asai Y; Iwata H; Ikemoto S; Hato F; Kishimoto T; Fukushima S
    Oncol Res; 1996; 8(3):139-44. PubMed ID: 8823810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High susceptibility of p53(+/-) knockout mice in N-butyl-N-(4-hydroxybutyl)nitrosamine urinary bladder carcinogenesis and lack of frequent mutation in residual allele.
    Ozaki K; Sukata T; Yamamoto S; Uwagawa S; Seki T; Kawasaki H; Yoshitake A; Wanibuchi H; Koide A; Mori Y; Fukushima S
    Cancer Res; 1998 Sep; 58(17):3806-11. PubMed ID: 9731488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 4-Hydroxybutyl(butyl)nitrosamine-induced urinary bladder cancers in mice: characterization of FHIT and survivin expression and chemopreventive effects of indomethacin.
    Lubet RA; Huebner K; Fong LY; Altieri DC; Steele VE; Kopelovich L; Kavanaugh C; Juliana MM; Soong SJ; Grubbs CJ
    Carcinogenesis; 2005 Mar; 26(3):571-8. PubMed ID: 15591090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Possible inhibitory effects of promotion stage treatment with thymosin fraction 5 on N-butyl-N-(4-hydroxybutyl)nitrosamine-initiated urinary tract carcinogenesis in NON/Shi mice.
    Murai T; Mori S; Hato F; Kinoshita Y; Fukushima S
    Int J Oncol; 1996 Jan; 8(1):117-24. PubMed ID: 21544339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dietary beta-cryptoxanthin inhibits N-butyl-N-(4-hydroxybutyl)nitrosamine-induced urinary bladder carcinogenesis in male ICR mice.
    Miyazawa K; Miyamoto S; Suzuki R; Yasui Y; Ikeda R; Kohno H; Yano M; Tanaka T; Hata K; Suzuki K
    Oncol Rep; 2007 Feb; 17(2):297-304. PubMed ID: 17203164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of phenacetin pretreatment on renal pelvic carcinogenesis by N-butyl-N-(4-hydroxybutyl)nitrosamine in NON/Shi mice of both sexes.
    Murai T; Mori S; Hosono M; Takeuchi Y; Oohara T; Makino S; Takeda R; Fukushima S
    Teratog Carcinog Mutagen; 1994; 14(4):193-201. PubMed ID: 7992231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduction in responsiveness of thymocytes to phytohemagglutinin during bladder tumor induction and restorative effects of thymosin fraction 5 in rats.
    Wada S; Kinoshita Y; Ozaki Y; Nishio S; Kimura S; Maekawa M
    J Natl Cancer Inst; 1987 Feb; 78(2):303-6. PubMed ID: 3492624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thymus lymphocytes in rats during induction of bladder tumors and effects of thymosin fraction 5 in vitro.
    Wada S; Ozaki Y; Nishio S; Maekawa M; Kimura S; Kinoshita Y
    J Natl Cancer Inst; 1985 Mar; 74(3):659-64. PubMed ID: 3856067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transgenic rats carrying copies of the human c-Ha-ras proto-oncogene exhibit enhanced susceptibility to N-butyl-N-(4-hydroxybutyl)nitrosamine bladder carcinogenesis.
    Ota T; Asamoto M; Toriyama-Baba H; Yamamoto F; Matsuoka Y; Ochiya T; Sekiya T; Terada M; Akaza H; Tsuda H
    Carcinogenesis; 2000 Jul; 21(7):1391-6. PubMed ID: 10874018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemoprevention of mouse urinary bladder carcinogenesis by fermented brown rice and rice bran.
    Kuno T; Hirose Y; Yamada Y; Hata K; Qiang SH; Asano N; Oyama T; Zhi H; Iwasaki T; Kobayashi H; Mori H
    Oncol Rep; 2006 Mar; 15(3):533-8. PubMed ID: 16465408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of results of agglutination assays with concanavalin A and carcinogenesis experiments on promoters of bladder cancer.
    Kakizoe T; Nishio Y; Ohtani M; Niijima T; Sato S; Sugimura T
    Jpn J Cancer Res; 1985 Oct; 76(10):930-6. PubMed ID: 3935624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal pelvic carcinoma which shows metastatic potential to distant organs, induced by N-butyl-N-(4-hydroxybutyl)nitrosamine in NON/Shi mice.
    Murai T; Mori S; Hosono M; Takeuchi Y; Ohara T; Makino S; Takeda R; Hayashi Y; Fukushima S
    Jpn J Cancer Res; 1991 Dec; 82(12):1371-7. PubMed ID: 1778760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of Lentinus edodes, Grifola frondosa and Pleurotus ostreatus administration on cancer outbreak, and activities of macrophages and lymphocytes in mice treated with a carcinogen, N-butyl-N-butanolnitrosoamine.
    Kurashige S; Akuzawa Y; Endo F
    Immunopharmacol Immunotoxicol; 1997 May; 19(2):175-83. PubMed ID: 9130004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of phenacetin and caffeine on N-butyl-N-(4-hydroxybutyl)-nitrosamine-initiated urothelial carcinogenesis in rats.
    Kunze E; Rath G; Graewe T
    Urol Int; 1987; 42(2):108-14. PubMed ID: 3617238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NTP Toxicology and Carcinogenesis Studies of Salicylazosulfapyridine (CAS No. 599-79-1) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1997 May; 457():1-327. PubMed ID: 12587019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of preventive efficacy of FK228, a histone deacetylase inhibitor, against N-butyl-N-(4-hydroxybutyl) nitrosamine-induced urinary bladder carcinogenesis in p53+/- and p53+/+ mice.
    Wei M; Wanibuchi H; Morimura K; Salim EI; Moku M; Doi K; Mitsuhashi M; Masuda C; Shen J; Kinoshita A; Fukushima S
    Anticancer Res; 2004; 24(2B):785-90. PubMed ID: 15161027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toxicology and carcinogenesis studies of indium phosphide (CAS No. 22398-90-7) in F344/N rats and B6C3F1 mice (inhalation studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2001 Jul; (499):7-340. PubMed ID: 12087422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NTP technical report on the toxicity studies of Dibutyl Phthalate (CAS No. 84-74-2) Administered in Feed to F344/N Rats and B6C3F1 Mice.
    Marsman D
    Toxic Rep Ser; 1995 Apr; 30():1-G5. PubMed ID: 12209194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.